Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Multilocus effects of the renin–angiotensin–aldosterone system genes on blood pressure response to a thiazide diuretic

The Pharmacogenomics Journal volume 4, pages 17–23 (2004)Cite this article

ABSTRACT

Background: The renin–angiotensin–aldosterone (RAA) system regulates blood pressure (BP) levels and influences responses to antihypertensive medications. Variation in RAA system genes has been reported to influence interindividual differences in BP levels and the occurrence of hypertension (HTN).

Methods: We evaluated the relationship between variation in genes of the RAA system and interindividual differences in BP response to a thiazide diuretic. Analyses were carried out in a race- and gender-specific manner in 255 unrelated hypertensive African-Americans (125 men and 130 women) and 246 unrelated hypertensive non-Hispanic Whites (133 men and 113 women).

Results: The angiotensin II receptor (AT1R) A1166C and angiotensinogen G-6A polymorphisms had a significant effect on systolic BP response to the diuretic in African-American women. Multilocus analyses indicated that the effects of these genes combined additively to influence response. Results of a permutation test to adjust for multiple comparisons and the possible nonindependence among genotypes remained significant at the P=0.003 level.

Conclusions: Among African-American women, particular gene variations in the RAA system have additive effects on BP response to a thiazide diuretic.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Beevers GD, MacGregor GA Hypertension in Practice, 3rd edn. Blackwell Science, Inc: Malden, MA 1999.

    Google Scholar 

  2. Elliott W Hypertension Therapy Annual. Blackwell Science Inc: Malden, MA 2000.

    Google Scholar 

  3. Kaplan MN Kaplna's Clinical Hypertension, 8th edn. Lippincott Williams and Wilkins: New York 2002.

    Google Scholar 

  4. Materson BJ, Reda DJ, Cushman WC, Massie BM, Freis ED, Kochar MS et al. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on antihypertensive Agents. N Engl J Med 1993; 328: 914–921.

    Article  CAS  Google Scholar 

  5. Chapman AB, Schwartz GL, Boerwinkle E, Turner S . Predictors of antihypertensive response to a standard dose of hydrochlorothiazide for essential hypertension. Kidney Int 2002; 61: 1047–1055.

    Article  CAS  Google Scholar 

  6. Pachori AS, Huentelman MJ, Francis SC, Gelband CH, Katovich MJ, Raizada MK . The future of hypertension therapy: sense, antisense or nonsense? Hypertension 2001; 37: 357–364.

    Article  CAS  Google Scholar 

  7. Soldner A, Spahn-Langguth H, Mutschler E . The renin–angiotensin–aldosterone system: focus on its distinct role in arterial hypertension and its various inhibitors as a therapeutic strategy to effectively lower blood pressure. Pharmazie 1996; 51: 783–799.

    CAS  PubMed  Google Scholar 

  8. Sidawy AN, Sumpio BE, DePalma RG The Basic Science of Vascular Biology. Futura Publishing Company Inc: Armonk, NY 1997.

    Google Scholar 

  9. Halushka MK, Fan JB, Bentley K, Hsie L, Shen N, Weder A et al. Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. Nat Genet 1999; 22: 239–247.

    Article  CAS  Google Scholar 

  10. Fox ST Human Physiology. Wm.C.Brown Publishers: Dubuque, IA 1984.

    Google Scholar 

  11. Turner ST, Boerwinkle E, Sing CF . Context-dependent associations of the ACE I/D polymorphism with blood pressure. Hypertension 1999; 34(Part 2): 773–778.

    Article  CAS  Google Scholar 

  12. Matsubara M, Kikuya M, Ohkubo T, Metoki H, Omori F, Fujiwara T et al. Aldosterone synthase gene (CYP11B2) C-334T polymorphism, ambulatory blood pressure and nocturnal decline in blood pressure in the general Japanese population: the Ohasama Study. J Hypertens 2001; 19: 2179–2184.

    Article  CAS  Google Scholar 

  13. Schwartz GL, Turner ST, Chapman AB, Boerwinkle E . Interacting effects of gender and genotype on blood pressure response to hydrochlorothiazide. Kidney Int 62: 1718–1723.

    Article  CAS  Google Scholar 

  14. Duncan JA, Scholey JW, Miller JA . Angiotensin II type 1 receptor gene polymorphisms in humans: physiology and pathophysiology of the genotypes. Curr Opin Nephrol Hypertens 2001; 1: 111–116.

    Article  Google Scholar 

  15. Inoue I, Nakajima T, Williams CS, Quackenbush J, Puryear R, Powers M et al. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 1997; 99: 1786–1797.

    Article  CAS  Google Scholar 

  16. Hunt SC, Geleijnse JM, Wu LL, Witteman JC, Williams RR, Grobbee DE . Enhanced blood pressure response to mild sodium reduction in subjects with the 235T variant of the angiotensinogen gene. Am J Hypertens 1999; 12: 460–466.

    Article  CAS  Google Scholar 

  17. Miller JA, Thai K, Scholey JW . Angiotensin II type 1 receptor gene polymorphism predicts response to losartan and angiotensin II. Kidney Int 56: 2173–2180.

  18. Jeunemaitre X, Gimenez-Roqueplo AP, Celerier J, Corvol P . Angiotensinogen variants and human hypertension. Curr Hypertens Rep 1999; 1: 31–41.

    Article  CAS  Google Scholar 

  19. Schwartz GL, Turner ST, Chapman AB, Boerwinkle E . Interacting effects of gender and genotype on blood pressure response to hydrochlorothiazide. Kidney Int 2002; 62: 1718–1723.

    Article  CAS  Google Scholar 

  20. Hingorani AD, Jia H, Stevens PA, Hopper R, Dickerson JE, Brown MJ . Renin–angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition. J Hypertens 1995; 13: 1602–1609.

    CAS  Google Scholar 

  21. Miller JA, Thai K, Scholey JW . Angiotensin II type 1 receptor gene polymorphism predicts response to losartan and angiotensin II. Kidney Int 1999; 56: 2173–2180.

    Article  CAS  Google Scholar 

  22. Williams SM, Addy JH, Phillips III JA, Dai M, Kpodonu J, Afful J et al. Combinations of variations in multiple genes are associated with hypertension. Hypertension 2000; 36: 2–6.

    Article  CAS  Google Scholar 

  23. Schwartz GL, Turner ST, Chapman AB, Boerwinkle E . Interacting effects of gender and genotype on blood pressure response to hydrochlorothiazide: interacting effects of gender and genotype on blood pressure response to hydrochlorothiazide. Kidney Int 62: 1718–1723.

    Article  CAS  Google Scholar 

  24. Sethi AA, Nordestgaard BG, Agerholm-Larsen B, Frandsen E, Jensen G, Tybjaerg-Hansen A . Angiotensinogen polymorphisms and elevated blood pressure in the general population. Hypertension 2001; 37: 875–881.

    Article  CAS  Google Scholar 

  25. Sethi AA, Nordestgaard BG, Agerholm-Larsen B, Frandsen E, Jensen G, Tybjaerg-Hansen A . Angiotensinogen polymorphisms and elevated blood pressure in the general populationthe Copenhagen City Heart Study. Hypertension 2001; 37: 875–881.

    Article  CAS  Google Scholar 

  26. Jeunemaitre X, Inoue I, Williams C, Charru A, Tichet J, Powers M et al. Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet 1997; 60: 1448–1460.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the US Public Health Service grants R01-HL5330, M01-RR00039, M01-RR00585, Grant No. 07574-01 from the National Institute for Nursing Research, National Institutes of Health, and funds from the Mayo Foundation.

Author information

Authors and Affiliations

  1. The University of Texas-Houston School of Nursing, Human Genetic Center and Institute of Molecular Medicine, USA

    L Frazier

  2. Division of Hypertension, Mayo Clinic, Rochester, MN, USA

    S T Turner & G L Schwartz

  3. Renal Division, Emory University, Atlanta, GA, USA

    A B Chapman

  4. Human Genetic Center and Institute of Molecular Medicine, Houston, TX, USA

    E Boerwinkle

Authors
  1. L Frazier
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S T Turner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G L Schwartz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A B Chapman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E Boerwinkle
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E Boerwinkle.

Additional information

DUALITY OF INTEREST

None declared.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Frazier, L., Turner, S., Schwartz, G. et al. Multilocus effects of the renin–angiotensin–aldosterone system genes on blood pressure response to a thiazide diuretic. Pharmacogenomics J 4, 17–23 (2004). https://doi.org/10.1038/sj.tpj.6500215

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.tpj.6500215

Keywords

This article is cited by

Search

Advanced search

Quick links